Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-003449
Filing Date
2022-05-16
Accepted
2022-05-16 13:08:44
Documents
52
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q phbi_10q.htm   iXBRL 10-Q 862726
2 CERTIFICATION phbi_ex311.htm EX-31.2 13517
3 CERTIFICATION phbi_ex321.htm EX-32.1 4418
  Complete submission text file 0001477932-22-003449.txt   3403930

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA phbi-20220331.xsd EX-101.SCH 44727
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE phbi-20220331_lab.xml EX-101.LAB 220248
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phbi-20220331_cal.xml EX-101.CAL 39825
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phbi-20220331_pre.xml EX-101.PRE 177822
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phbi-20220331_def.xml EX-101.DEF 91357
46 EXTRACTED XBRL INSTANCE DOCUMENT phbi_10q_htm.xml XML 404407
Mailing Address 2987 BLACKBEAR COURT COQUITLAM A1 V3E3A2
Business Address 2987 BLACKBEAR COURT COQUITLAM A1 V3E3A2 702-803-9404
Pharmagreen Biotech Inc. (Filer) CIK: 0001435181 (see all company filings)

EIN.: 980491567 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-56090 | Film No.: 22927302
SIC: 4581 Airports, Flying Fields & Airport Terminal Services